Rationale Despite widespread abuse, there are few validated methods to study the rewarding effects of inhalants. One model that may have utility for this purpose is intracranial self-stimulation (ICSS). Objectives This study aims to compare and contrast the ICSS reward-facilitating effects of abused inhalants to other classes of abused drugs. Compounds were examined using two different ICSS procedures in mice to determine the generality of each drug's effects on ICSS and the sensitivity of the procedures. Methods Male C57BL/6J mice with electrodes implanted in the medial forebrain bundle were trained under a threecomponent rate-frequency as well as a progressive ratio (PR) ICSS procedure. The effects of nitrous oxide, toluene vapor, cocaine, and diazepam on ICSS were then examined. Results Concentrations of 1,360-2,900 parts per million (ppm) inhaled toluene vapor significantly facilitated ICSS in the rate-frequency procedure and 1,360 ppm increased PR breakpoint. A concentration of 40 % nitrous oxide facilitated ICSS in the rate-frequency procedure but reduced PR breakpoint. Doses of 3-18 mg/kg cocaine facilitated ICSS in the rate-frequency procedure, and 10 and 18 mg/kg increased PR breakpoint. Doses of 1 and 3 mg/kg diazepam facilitated ICSS in the rate-frequency procedure, and 3 mg/kg increased PR breakpoint. Conclusions The reinforcement-facilitating effect of toluene in ICSS is at least as great as diazepam. By contrast, nitrous oxide weakly enhances ICSS in only the rate-frequency procedure. The data suggest that the rate-frequency procedure may be more sensitive than the PR schedule to the rewardfacilitating effects of abused inhalants.
Introduction
Nitrous oxide and toluene are two commonly abused inhalants. Toluene is a volatile aromatic hydrocarbon found in a wide range of consumer and industrial products including paint thinner, glues, and gasoline. Nitrous oxide is a gas used clinically as an anesthetic adjunct in medicine and dentistry (Balster et al. 2009; Brouette and Anton 2001) . Inhaled toluene produces a rapid onset of psychoactive effects, including excitation, euphoria, incoordination, and hallucinations (Cruz and Domínguez 2011; Elkoussi and Bakheet 2011) . Nitrous oxide also produces a myriad of psychoactive effects including euphoria, fatigue, numbing sensations, and detachment (Walker and Zacny 2003; Zacny et al. 2008; Cho et al. 1997; Collado et al. 2007 ). Chronic toluene and nitrous oxide abuse each have severe medical consequences. Toluene exposure causes neurotoxicity as well as reproductive, pulmonary, renal, cardiovascular, and hepatic organ system damage (Bowen and Hannigan 2006; Gupta et al. 2011; Hannigan and Bowen 2010; Hoet and Lison 2008; Yücel et al. 2008) . Chronic nitrous oxide abuse has been associated with vitamin B12 deficiency and myeloneuropathies (Lin et al. 2011; Tatum et al. 2010) .
Despite being inexpensive, readily available and of high abuse liability, the mechanism or mechanisms underlying the rewarding effects of toluene and nitrous oxide are poorly understood (Bowen and McDonald 2009; Garland et al. 2009 ). One reason this may be the case is the absence of validated in vivo procedures for examining their abuse-related effects. While the intravenous self-administration procedure is the most widely utilized behavioral paradigm to assess drug reinforcement, it is difficult to conduct self-administration studies with inhalants. To date only one study has demonstrated intravenous self-administration of an inhalant in rodents and that experiment used a unique between-subject single day acquisition procedure in mice which is poorly suited to longitudinal behavioral studies (Blokhina et al. 2004) .
One procedure which may be adaptable to examining the reward-related effects of inhalants is intracranial selfstimulation (ICSS). Most classes of abused drugs facilitate ICSS-reinforced behavior (Kornetsky et al. 1979; Wise 1980; Fish et al. 2010; Straub et al. 2010) . The development of ICSS procedures to examine the reward-related effects of inhalants in mice is of particular interest given the powerful genetic tools available only in mice. For example, knock-in mice with subtype-specific GABA A point site mutations have been utilized to investigate which subtypes contribute to the behavioral effects of alcohol and benzodiazepines (Blednov et al. 2011; Reynolds et al. 2012) . These same strategies could also be applied to inhalants to delineate receptor systems and subtypes responsible for mediating their reward-like effects.
Two studies in rats have demonstrated that, similar to other drugs of abuse, toluene vapor facilitates ICSS (Yavich and Zvartau 1994; Bespalov et al. 2003) . It has also recently been demonstrated that I.P.-injected toluene reduces ICSS thresholds in mice in a discrete-trial current-threshold procedure (Chan et al. 2012) . Mimicking the route a drug is abused in humans has traditionally been thought to be of limited importance in preclinical studies, therefore the most convenient injection route is typically utilized. However, c-Fos expression in rats showed administration route-dependent differences in neuronal activation produced by toluene (Perit et al. 2012) . Among the important neuronal systems differentially affected by route were areas associated with reward and motor control, with inhaled toluene producing significant increases in c-Fos expression in the nucleus-accumbens core and caudateputamen relative to the findings of a previous study using injected toluene (Lo and Chen 2005) . While c-Fos is only a proxy for neuronal activation, this data coupled with the fact that toluene is abused exclusively by inhalation supports studying the reward altering effects of liquid volatile inhalants by the inhalation route. In addition, the use of inhalation exposure is the only route through which abused gaseous compounds such as nitrous oxide can be examined.
The goals of the present study were to develop and characterize ICSS procedures to assess the reward-related effects of inhalational delivery of abused inhalants in mice. The effects of toluene and nitrous oxide on ICSS were examined using both rate-frequency and progressive ratio (PR) procedures to determine the generality of any effects on reinforcement as well as the relative sensitivity of both procedures. As a positive control, we examined cocaine as it produces robust facilitation of ICSS (Fish et al. 2010; Straub et al. 2010) . Lastly, given that toluene and nitrous oxide both have positive GABA A modulatory effects, for comparison we also examined diazepam (Bowen et al. 1996; Cruz et al. 1998; Emmanouil et al. 1994; Hapfelmeier et al. 2000) .
Materials and methods

Subjects
A total of 23 adult C57BL/6J mice were used (Jackson Laboratory, Bar Harbor, Maine). Mice were individually housed under a 12-h light/dark cycle (lights on a 0600). Mice were tested M-F between 0800 and 1800. Chow (Harlan, Madison, WI) and water were available ad libitum except during experimental sessions. All procedures were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University and were in accordance with the NIH "Guide for the Care and Use of Laboratory Animals: Eighth edition" (National Research Council 2011).
Compounds HPLC-grade toluene was purchased from Fisher Scientific. Cocaine hydrochloride was obtained from the National Institute on Drug Abuse drug supply program and prepared in 0.9 % sterile saline. Diazepam was obtained in an injectable commercial formulation and diluted in 0.9 % sterile saline. Medical-grade nitrous oxide and oxygen cylinders were purchased from National Welders (Richmond, VA).
Surgical procedure
Mice were anesthetized with isoflurane vapor and implanted with 6 mm bipolar electrodes (Plastics One, Roanoke, Virginia) into the right medial forebrain bundle within the lateral hypothalamus (Paxinos and Franklin 2001) . Coordinates relative to Bregma were: −1.5 anterior-posterior, 1.0 mediallateral, and −5.0 dorsal-ventral. Three stainless steel screws were affixed in holes in the skull to serve as anchors for a dental acrylic headpiece. Mice were treated daily for 3 days postsurgery with 0.5 mg/kg of the analgesic carprofen. Mice were allowed 6 days to recover prior to beginning ICSS training sessions.
Dynamic exposure system and testing apparatus
The inhalant exposure ICSS system consisted of four 20-L acrylic cubicles each of which contained a two-lever operant conditioning chamber (Med-Associates, St. Albans, VT). A bipolar lead tether connection (Plastics One, Roanoke, VA) and Mercotac 205L mercury commutator (Mercotac, Carlsbad CA) was suspended above the operant conditioning chamber by a counterbalanced arm. Toluene vapor was produced using a dynamic vapor generator composed of a filtered, pressure regulated air supply routed via tubing to two mass flow proportional valves controlled by a Matheson 8284 dynamic gas mixer (Matheson, Albuquerque, NM). The air output from one valve passed through a fritted glass bubbler inserted in a three-neck round flask filled with liquid toluene, generating a toluene-laden air stream. The toluene-laden air was mixed with metered fresh air from the second mass control valve permitting a broad range of highly reproducible inhalant concentrations to be generated. The blended vapor stream was routed through the upper rear wall of the operant conditioning chambers via Tygon tubing. The effluent mixture was vented from bottom rear wall of the exposure chamber through a Miran 1A single wavelength infrared spectrophotometer coupled to a computerized chart recorder (DATAQ, Akron, OH), providing real time inhalant concentration measurement relative to a previously generated standard curve. Toluene concentrations within each ICSS chamber were also quantified by headspace gas chromatography. To deliver nitrous oxide, the system was similar except the inhalant and mix gas sources were provided by compressed cylinders. ICSS stimulation and operant schedule control was provided by commercially available components (MedAssociates, St. Albans, VT). A schematic of the operant conditioning chamber housed within the gas exposure system is shown in Fig. 1 .
Rate-frequency ICSS procedure
After surgical recovery, mice were trained to respond in daily 1-h sessions for brain stimulation under a fixed ratio 1 (FR1) schedule of reinforcement. Each active lever-press resulted in electrical stimulation consisting of a 500-ms 158-Hz pulse train. Current amplitude for each subject was adjusted within a range of 50 to 300 μA to generate maximal rates of responding. When responding stabilized under these conditions, the mice progressed to the three component sessions used for rate-frequency testing. Training and test sessions were 70 min in duration, divided into three 10-min response components separated by two 20-min timeouts. The timeout periods served as pretreatment windows prior to the second and third ICSS response components. Vehicle or air was administered during the first 20-min timeout. Drugs were injected or inhalant exposures initiated during the second 20-min timeout. In this manner baseline control ICSS data (second response component) as well as test data (third response component) could be generated within the same subject on the same test day. Treatment exposures of inhalants initiated at the start of the second timeout continued through the third response component resulting in 30 min of total inhalant exposure. Response components were signaled by the illumination of the chamber house light. During initial training, each active lever press during the 10-min response components delivered a 500-ms pulse train. After responding under the multiple component schedule, stabilized animals were transitioned to sessions in which the frequency available for self-stimulation began at 158 Hz and decreased each min thereafter by 0.05 log units ending at 56 Hz on the last min of each component. After behavior again stabilized, as defined by consistent response rates of ≥30 responses/min and lever pressing for at least four self-stimulation frequencies of the rate-frequency curve, testing began. At any point in the progression of training, animals which failed to respond reliably were removed from the study and replaced.
Toluene concentrations of 480, 1,360, 2,900, 3,300, and 5,000 parts per million (ppm) were examined. Nitrous oxide concentrations of 5, 20, 40, 60, and 80 % combined with oxygen were also examined in an identical exposure design. Sessions in which injected drugs were given were identical to inhalant test sessions with the exception that following the second response Fig. 1 Schematic representation of the experimental apparatus constructed to expose mice to toluene vapor. A dynamic gas mixer controlled the flow rate of compressed air directed through a 1-L glass bubbler container partially filled with liquid toluene. The toluene vapor laden air stream thus generated was then proportionally mixed with a clean air stream before being directed into a 20-L exposure cubicle housing an operant conditioning chamber. Effluent from the exposure chamber was routed through an IR spectrometer connected to a computerized chart recorder to monitor real-time exposure chamber concentrations. N 2 O delivery was identical except that nitrous oxide gas and medical oxygen were delivered from compressed cylinders and the bubbler was not utilized component the mice were given an I.P. injection of drug. Cocaine was tested at doses of 3, 10, and 18 mg/kg and diazepam was tested at doses of 0.3, 1, 3, and 10 mg/kg diazepam.
Inhalant concentrations and test drug doses were generally tested in an ascending order. In mice which advanced most rapidly through testing, it was sometimes necessary to then test lower doses/concentrations to adequately characterize the full dose/concentration-effect curve. The ascending dose series was then updated for subsequent subjects. Upon completion of a dose/concentration-effect curve, subjects were assigned to the next planned experimental condition requiring additional subjects. Drug naïve subjects which replaced those animals lost to electrode failures or other causes were counterbalanced across test conditions with subjects with previous drug exposure to ensure that individual conditions contained similar numbers of naïve and experienced subjects.
Progressive ratio ICSS procedure
Following completion of rate-frequency testing, the animals were transitioned to a chain PR/FR schedule (Depoortere et al. 1999) . Under the PR/FR schedule, the number of leverpresses required to increment the schedule was increased after each completed component. The PR step-size was increased according to an exponential step size function (5*e (trial#*0.1) −5) (Sharma et al. 2012) . After each PR was completed the animal received five, 500 ms ICSS pulse trains over five sec and then entered a second component in which the next ten FR1 responses were each reinforced by one 500 ms ICSS pulse train. Following the completion of the FR1 component the PR value incremented to the next higher ratio value and the PR/FR sequence repeated until a PR requirement was not completed within 6 min, terminating the session. During PR/ FR training and testing the ICSS frequency was fixed at 158 Hz and the current amplitude for each mouse was the same as that used in the rate-frequency procedure. Concentrations of 100, 480, 1,360, and 2,900 ppm toluene and 20, 40, and 80 % nitrous oxide combined with oxygen were administered 20 min prior to and for the duration of the PR/FR session. Diazepam was tested at doses of 0.3, 1, 3, and 6 mg/kg administered 15 min prior to the start of the PR/FR session. Cocaine was tested at doses of 3, 10, and 18 mg/kg administered 5 min prior to the start of the PR/FR session.
Quantification of exposure concentrations and inhalant blood levels
Blood toluene concentrations were determined by submandibular blood sampling following 20 min of exposure to 480, 1,360, 3,300, and 5,000 ppm toluene and after 30 min exposure to 3,300 ppm. The headspace gas chromatography analytical methods were similar to those previously reported (Shelton 2009; Shelton and Nicholson 2012; Shelton and Nicholson 2010) .
Data analysis
In the three component procedure, data from the first 10-min response component was discarded as it has been shown to exhibit more variability compared with subsequent components (Carlezon and Chartoff 2007) . Stimulations earned during each 1-min trial of the second 10-min air/vehicle exposure control component were compared with the equivalent trial in the third 10-min drug test component. For each mouse, data from each trial were expressed as a percentage of the number of stimulations in the 1-min trial with the greatest number of responses, regardless of frequency, in the second baseline component. The values are reported as a percentage of the maximum control responses (%MCR). This data normalization procedure allowed grouping of the data across subjects despite differences in individual maximum response rates. Data from the second control and third test component were compared individually for each drug dose or inhalant concentration by two-way within subject repeated measures analysis of variance (ANOVA) according to previous literature (Altarifi and Negus 2011; Bauer et al. 2013; Bonano et al. 2013 ). GraphPad version 6.01 for Windows (La Jolla, CA) was used for all analyses. Significant (p <0.05) main effects and interactions were subsequently examined by Holm-Sidak post-hoc tests comparing identical frequencies between the control and test component.
Rate-frequency data was also analyzed to calculate M50 values for each treatment condition using a variant of the method outlined in Carlezon and Chartoff (2007) . M 50 values represent the interpolated frequency that maintains 50 % maximum response rates. The estimated linear portion of the rate-frequency curve from 20-80 % of %MCR was analyzed for each subject using a least-squares regression line of best fit to estimate M50. Group treatment condition M 50 were then compared by student's paired t test to group vehicle control baseline to determine whether the %M 50 shift was significant (p <0.05).
In the PR procedure, test condition breakpoint data were normalized by expressing them as a change in breakpoint from each subject's baseline control breakpoint. The average breakpoint of the two mid-week vehicle (air or saline) test sessions was defined as the baseline breakpoint. Change in breakpoint resulting from drug exposure was calculated by subtracting the baseline breakpoint from the test breakpoint for each subject. Group mean changes in breakpoints were then compared across drug or inhalant doses by one-way within subject repeated measures ANOVA. Significant (p < 0.05) main effects were examined by Holm-Sidak post hoc tests comparing changes in breakpoint for drug and inhalant exposure conditions to either air or saline.
Results
Rate-frequency procedure
Doses of 3, 10, and 18 mg/kg cocaine significantly facilitated ICSS (Fig. 2a-c) . There was a significant main effect of 3 mg/kg cocaine (F (1, 10)=15.68, p =0.0027) (Fig. 2a) on ICSS responding but no drug×frequency interaction (F (1, 10)= 1.121, p =0.3561). There was a significant drug×frequency interaction (F (9, 90)=2.480, p =0.0141) of 10 mg/kg cocaine on %MCR (Fig. 2b) with responding at the six lowest frequencies significantly increased over control. There was a significant drug×frequency interaction (F (9, 90)=4.278, p = 0.0001) of 18 mg/kg cocaine on %MCR (Fig. 2c) with the seven lowest frequencies showing significantly higher rates of responding compared with control. Cocaine doses of 3 (t (10)=2.961, p =0.0143) and 10 mg/kg (t (10)=3.101, p =0.0112) significantly lowered the M 50 (Table 1) . A M50 value for 18 mg/kg cocaine could not be calculated as responding was too robustly increased across the entire ICSS frequency range to permit the analysis.
In the rate-frequency procedure, 1 and 3 mg/kg diazepam significantly facilitated and 10 mg/kg significantly depressed ICSS (Fig. 3a-d ). There was a significant main effect of 1 mg/kg diazepam (F (1, 8)=5 .478, p =0.0474) (Fig. 3b) but no drug×frequency interaction (F (9, 72)=1.374, p = 0.2160). There was a significant drug×frequency interaction (F (9, 72)=3.473, p =0.0013) of 3 mg/kg diazepam on %MCR (Fig. 3c ) with responding at five of six of the lowest frequencies significantly increased over control. There was a significant drug × frequency interaction of 10 mg/kg diazepam on %MCR (F (9, 72) = 2.624, p = 0.0111) (Fig. 2d) (Table 1) .
There was a linear relationship between toluene vapor exposure concentration and toluene blood concentration (Fig. 4) . The lowest exposure concentration of 480 ppm toluene produced a mean blood concentration of 3.7 μg/mL after 20 min of exposure increasing to 61.2 μg/mL at the highest, 5,000 ppm toluene exposure concentration. To determine the extent to which toluene blood concentration may have increased during the third ICSS response component we also examined toluene blood levels after 30 min of exposure to the intermediate concentration of 3,300 ppm. Exposure to 3,300 ppm toluene for 30 min resulted in only a 15 % increase compared with exposure for 20 min (data not shown).
Concentrations of 1,360-5,000 ppm toluene all produced significant effects on ICSS (Fig. 5a-f ). There was a significant interaction (F (9, 90)=7.134, p <0.0001) of 1,360 ppm toluene on ICSS with six of ten frequencies showing significantly greater %MCR (Fig. 5b ) compared with control. There was significant interaction (F (9, 90)=2.455, p = 0.0151) of 2,000 ppm toluene on ICSS with seven of ten frequencies showing significantly greater %MCR (Fig. 5c ) compared with control.
There was a significant interaction of 2,900 ppm toluene (F (9, 90)=5.200, p <0.0001) on %MCR ( Fig. 5d ) with the two lowest frequencies showing a significant enhancement of ICSS responding compared with control. There was a significant interaction of 3,300 ppm toluene (F (9, 90)=7.136, p <0.0001) on %MCR (Fig. 5e) on ICSS with the two highest frequencies demonstrating a significant depression and the two lowest frequencies a significant enhancement of ICSS responding compared with control. The 5,000-ppm toluene concentration produced a significant interaction (F (9, 90)=8.499, p <0.0001) on %MCR ( Fig. 5f ) with seven of ten frequencies exhibiting a (Table 1) and 2,000 ppm significantly decreased the M 50 (t (10)=3.652, p =0.0045) ( Table 1) .
Nitrous oxide concentrations of 40, 60, and 80 % all significantly altered ICSS responding (Fig. 6a-d ). There was a significant interaction (F (9, 54)=2.400, p =0.0228) of 40 % nitrous oxide on ICSS with two of ten frequencies showing significantly greater %MCR than control (Fig. 6b) . The 60 % nitrous oxide concentration produced a significant interaction (F (9, 54)=3.101, p =0.0045) with the highest frequency showing a significantly lower %MCR than control (Fig. 6c) . The highest, 80 % nitrous oxide concentration produced a significant interaction (F (9, 54)= 9.944, p <0.0001) on %MCR ( Fig. 6d ) with 5 of 10 frequencies showing suppressed rates of ICSS responding compared with control. Nitrous oxide at 40 % also significantly lowered the M 50 (t (6)= 3.771, p =0.0093) ( Table 1) .
Progressive ratio procedure
Cocaine significantly increased progressive-ratio breakpoint (F (1.280, 7.681)=9.534, p= 0.0126) (Fig. 7a) . Post hoc tests revealed that 10 and 18 mg/kg cocaine significantly (p <0.05) increased breakpoint compared with saline control. Diazepam condition; a 480, b 1,360, c 2,900, and d 3,300, and e 5,000 ppm toluene. *p <0.05, significant differences compared with saline control significantly increased (F (2.657, 18.60)=4.447, p =0.0189) progressive-ratio breakpoint (Fig. 7b) . Post hoc tests revealed that 3 mg/kg diazepam significantly increased breakpoint compared with saline control. Toluene (Fig. 7c ) also significantly increased breakpoint (F (2.462, 17.23)=7.964, p =0.0023). Post hoc tests revealed that the 1,360 ppm toluene concentration significantly increased breakpoint compared with air control. Nitrous oxide (Fig. 6d ) significantly decreased ICSS breakpoints (F (1.719, 10.32)=5.400, p =0.0282). Post hoc tests revealed that the 40 and 80 % nitrous oxide concentrations significantly (p <0.05) decreased breakpoint compared with the air control.
Discussion
As expected, cocaine produced a robust dose-dependent facilitation of ICSS responding at all three tested doses ( Fig. 2a-c) . These data are in agreement with previous literature examining cocaine treated C57BL/6J mice in the ratefrequency ICSS procedure (Fish et al. 2010; Straub et al. 2010) . The positive GABA A allosteric modulator diazepam ( Fig. 3a-d ) produced a less robust biphasic effect on ICSS in the rate-frequency procedure. The 0.3-mg/kg diazepam dose did not alter ICSS, 1 and 3 mg/kg doses facilitated ICSS, and the 10-mg/kg dose suppressed ICSS. Similarly, the 3-mg/kg dose of diazepam also significantly increased ICSS breakpoint in the PR procedure (Fig. 7a) . Our data are consistent with previous ICSS studies in mice that utilized a different curveshift ICSS procedure. These studies in C57BL/6J mice showed no effect of 0.3 mg/kg diazepam and a significant facilitation of ICSS by 1-4 mg/kg diazepam (Reynolds et al. 2012; Straub et al. 2010) . Taken together these data confirm that diazepam reliably facilitates ICSS in mice across multiple ICSS procedure variants. Overall, our data with cocaine and diazepam demonstrate that the three component rate-frequency and PR ICSS test conditions we employed are sensitive to the rewardfacilitating effects of abused drugs. The present data substantially extend the conditions under which it can be demonstrated that toluene will facilitate ICSS to include both the rate-frequency and progressive-ratio ICSS procedure variants. However, in contrast to cocaine which facilitated ICSS across the entire tested dose range, toluene produced a complex pattern of rate increasing and decreasing effects more comparable to our second positive control diazepam. Specifically, intermediate toluene concentrations facilitated ICSS in both the rate-frequency and the PR procedure. Moderately high toluene concentrations produced a biphasic effect, facilitating ICSS at low frequencies and suppressing ICSS at high frequencies while having no effect on PR responding. The highest toluene concentration suppressed ICSS regardless of stimulation frequency in the rate-frequency procedure. In ICSS, an enhancement of responding for stimulation following drug pretreatment is usually interpreted as a facilitation of brain reward circuitry (Wise et al. 1992) . In contrast, a depression of ICSS responding by a test drug has multiple interpretations (Carlezon and Chartoff 2007) . The first is that the pretreatment drug is producing anhedonic-like effects, reducing the subject's sensitivity to the reinforcing effects of brain stimulation. For example, it has been shown that the kappa-opioid receptor agonist U69,593 produces a characteristic anhedonic-like effect when administered alone as well as blocking the reinforcement enhancing effects of ICSS produced by cocaine (Tomasiewicz et al. 2008) . It is unclear if toluene is producing anhedonic-like effects in the present study although it is possible given previous data demonstrating that extended exposure to 1,650-3,300 ppm toluene vapor for 4 h can produce a conditioned taste aversion (Miyagawa et al. 1984) . However, in a conditioned place preference study, a significant preference for an environment paired with a shorter 30 min of exposure to 2,000 and 3,000 ppm toluene was observed while exposure to 5,000 ppm toluene failed to produce a place preference, possibly indicating the recruitment of anhedonic-like effects at this higher concentration (Lee et al. 2006) . Interestingly, at the same 5,000 ppm toluene concentration we observed a significant depression in responding in our ICSS rate-frequency procedure.
A second interpretation of depression of ICSS responding is that the test drug interferes with the ability of the subjects to physically perform the operant. For example, the sedative zolpidem has been shown to decrease operant performance in ICSS in the rate-frequency procedure (Reynolds et al. 2012) . It is certainly possible that this could be responsible for the suppression of ICSS at 5,000 ppm toluene given that exposure to 15 min of 8,000 ppm toluene vapor suppresses locomotor activity in C57BL/6J mice ). Exposure to concentrations of toluene vapor greater than 2,000-3,000 ppm suppress operant responding under fixed ratio as well as fixed interval schedules in mice (Moser and Balster 1985; Bowen and Balster 1998) suggesting that operant responding is even more sensitive to motor incoordination effect of toluene than locomotor activity. However, in the present study the effect of toluene at 3,300 ppm was ICSS frequency dependent with responding at low ICSS frequencies increased by toluene whereas responding was suppressed at high ICSS frequencies. This effect could have been due to motor incoordination manifesting itself primarily at the high frequencies which supported the greatest rates of responding but it may also Fig. 7 a Mean (±SEM) change in progressive-ratio breakpoint relative to saline control for 3, 10, and 18 mg/kg I.P. injected cocaine. b Mean (±SEM) change in progressive-ratio breakpoint relative to saline control for 0.3, 1, 3, and 6 mg/kg I.P. injected diazepam. C Mean change in progressive-ratio breakpoint relative to air control for exposure to 110, 480, 1,360, and 2,900 ppm toluene. d Mean change in progressive-ratio breakpoint relative to air control for exposure to 20, 40, and 80 % nitrous oxide. *p <0.05, significant differences compared with saline control suggest a classic rate-dependent effect (Dews 1977 ). This latter interpretation is possible, although under fixed interval schedules for food maintained responding response-rate increasing effects of toluene in mice are either not apparent (Bowen and Balster 1998) or extremely modest (Moser and Balster 1986) . Additional studies will be necessary to further explore these possibilities as they relate to ICSS performance.
The facilitation of ICSS by nitrous oxide was much less pronounced than that produced by toluene, diazepam, or cocaine. In the rate-frequency procedure 40 % nitrous oxide facilitated ICSS, although only significantly so at two intermediate stimulation frequencies (Fig. 6b) . The 60 % and 80 % nitrous oxide concentrations suppressed ICSS in the rate-frequency procedure and both 40 % and 80 % nitrous oxide suppressed PR responding. Prior preclinical studies examining the rewarding effects of nitrous oxide have also generated conflicting results. Squirrel monkeys will selfadministered a combination of 60 % N 2 O/40 % O 2 (Wood et al. 1977) . However, in a rat place conditioning and selfadministration study, repeated pairings of an environment with 40 min of exposures to 30 and 60 % nitrous oxide produced a conditioned place aversion (Ramsay et al. 2003) and inconsistent results in self-administration. Human selfadministration and subjective tests of N 2 O exposure have been equally divergent among healthy subjects. In human subjects given the option to self-administer 30 % N 2 O, oxygen vehicle, or air, but blinded to the identity of their choice, 5 of 12 subjects consistently chose N 2 O, 4 consistently avoided N 2 O, and 3 subjects were divided between N 2 O and the oxygen/placebo alternatives (Walker and Zacny 2001) . Taken together the present results and previous studies suggest that the rewarding effects of nitrous oxide at least as measured by self-administration, ICSS and conditioned place preference are at best fairly modest compared with other drugs of abuse including other inhalants such as toluene.
In summary, our findings indicate that toluene robustly facilitates PR ICSS breakpoint and enhances the reinforcing efficacy of low to mid-range frequencies of stimulation in the rate-frequency procedure. By contrast, N 2 O only weakly facilitates ICSS responding in the rate-frequency procedure and produced a concentration dependent suppression of ICSS breakpoint. These results suggest that while demonstrating some reinforcement enhancing effects on brain reward systems, N 2 O may also produce effects which more strongly compete with behaviors necessary to progress in the PR procedure relative to rate-frequency schedule. In the rate-frequency procedure, every lever-press results in some degree of stimulation, the production of interfering behaviors may have a much more limited effect on response output as compared with the PR procedure which requires successively greater numbers of responses in the absence of reinforcer presentation.
Given the relative difficulty of quantifying the reinforcing effects of inhaled substances using standard measures of drug reinforcement, developing alternative procedures is important for advancing our knowledge in the area. Our data with both toluene and nitrous oxide in mice suggest that ICSS is a viable method to probe the neurobiological mechanisms underlying the rewarding effects of abused inhalants.
